Parkinson’s disease is a progressive neurodegenerative disorder primarily affecting motor control due to degeneration of dopaminergic neurons in the substantia nigra. It is characterized by a combination of motor and non-motor symptoms that evolve gradually over time. Parkinson’s disease typically presents in later adulthood but may occur earlier in some individuals.

The cardinal motor features include bradykinesia, resting tremor, muscular rigidity, and postural instability. Non-motor symptoms such as cognitive impairment, mood disorders, sleep disturbances, autonomic dysfunction, and sensory symptoms are increasingly recognized as major contributors to disability. The clinical diagnosis is based on characteristic features and response to dopaminergic therapy.

Neurological management of Parkinson’s disease is long-term and highly individualized. Pharmacological therapy aims to restore dopaminergic balance and improve motor function. Treatment regimens are adjusted over time to address disease progression and medication-related complications.

Regular neurological follow-up is essential to monitor symptom evolution, optimize therapy, and manage complications such as motor fluctuations and dyskinesias. Non-motor symptoms require targeted management and significantly influence quality of life.

Parkinson’s disease impacts functional independence and psychosocial wellbeing. Neurologists coordinate multidisciplinary care, including physiotherapy, speech therapy, and cognitive support, to preserve mobility and daily function.

In Dubai, Parkinson’s disease care follows international neurological standards, emphasizing early diagnosis, personalized treatment strategies, and comprehensive long-term monitoring.